Plant Stanol Ester Beverage and Ileostoma Patients
STOMA
Effects of a Plant Stanolester Beverage on Cholesterol Metabolism Among Human Subjects With Ileostoma
2 other identifiers
interventional
10
1 country
1
Brief Summary
We aim to examine efficacy of a plant stanolester beverage to lower serum cholesterol and LDL-cholesterol levels, when given with or without a fatty acid preparation. Study subjects are otherwise healthy proctocolectomized ileostoma patients (n=10), who consume stanolester beverage with or without a fatty acid preparation in a random order for one week period after a standardized low-fat meal. Washout period is 4 weeks. Serum lipids, lipoprotein lipids, sterols and fecal sterols and variables of cholesterol metabolism will be examined accordingly.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2009
CompletedFirst Submitted
Initial submission to the registry
February 18, 2009
CompletedFirst Posted
Study publicly available on registry
February 19, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2010
CompletedFebruary 10, 2011
February 1, 2009
1.2 years
February 18, 2009
February 9, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
serum cholesterol level
After treatment perdiods
Interventions
Plant stanol ester 2gr/day and fatty acid in a beverage compared to plant stanol ester 2gr /day and placebo
Eligibility Criteria
You may qualify if:
- healthy proctocolectomized subjects with an ileostoma
You may not qualify if:
- Chronic illness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Helsinki, Department of Medicine
Helsinki, 00029, Finland
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Markku J. Nissinen, MD,PhD
University of Helsinki
- STUDY DIRECTOR
Tatu Miettinen, Professor
University of Helsinki
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
February 18, 2009
First Posted
February 19, 2009
Study Start
February 1, 2009
Primary Completion
May 1, 2010
Study Completion
May 1, 2010
Last Updated
February 10, 2011
Record last verified: 2009-02